AAT trial completed (phase I)

[rvm1212]

Kamada completes Phase I trial for lung disease treatment
The company has obtained orphan drug status for aerosolized ATT for congenital emphysema and cystic fibrosis.
<a target=_blank class=ftalternatingbarlinklarge href="http://www.globes.co.il/serveen/globes/docview.asp?did=1000298542&fid=1725
">http://www.globes.co.il/servee...d=1000298542&fid=1725
</a>
Its phase I yet, but it´s always good that they are looking for new treatments <img src="i/expressions/face-icon-small-smile.gif" border="0">

 

[rvm1212]

Kamada completes Phase I trial for lung disease treatment
The company has obtained orphan drug status for aerosolized ATT for congenital emphysema and cystic fibrosis.
<a target=_blank class=ftalternatingbarlinklarge href="http://www.globes.co.il/serveen/globes/docview.asp?did=1000298542&fid=1725
">http://www.globes.co.il/servee...d=1000298542&fid=1725
</a>
Its phase I yet, but it´s always good that they are looking for new treatments <img src="i/expressions/face-icon-small-smile.gif" border="0">

 

[rvm1212]

Kamada completes Phase I trial for lung disease treatment
The company has obtained orphan drug status for aerosolized ATT for congenital emphysema and cystic fibrosis.
<a target=_blank class=ftalternatingbarlinklarge href="http://www.globes.co.il/serveen/globes/docview.asp?did=1000298542&fid=1725
">http://www.globes.co.il/servee...d=1000298542&fid=1725
</a>
Its phase I yet, but it´s always good that they are looking for new treatments <img src="i/expressions/face-icon-small-smile.gif" border="0">

 

[rvm1212]

Kamada completes Phase I trial for lung disease treatment
The company has obtained orphan drug status for aerosolized ATT for congenital emphysema and cystic fibrosis.
<a target=_blank class=ftalternatingbarlinklarge href="http://www.globes.co.il/serveen/globes/docview.asp?did=1000298542&fid=1725
">http://www.globes.co.il/servee...d=1000298542&fid=1725
</a>
Its phase I yet, but it´s always good that they are looking for new treatments <img src="i/expressions/face-icon-small-smile.gif" border="0">

 

[rvm1212]

Kamada completes Phase I trial for lung disease treatment
The company has obtained orphan drug status for aerosolized ATT for congenital emphysema and cystic fibrosis.
<a target=_blank class=ftalternatingbarlinklarge href="http://www.globes.co.il/serveen/globes/docview.asp?did=1000298542&fid=1725
">http://www.globes.co.il/servee...d=1000298542&fid=1725
</a>
Its phase I yet, but it´s always good that they are looking for new treatments <img src="i/expressions/face-icon-small-smile.gif" border="0">

 

[LisaV]

Thanks
This is really interesting to me as my late husband's family carries the genes for both alpha-one anti trypsin deficiency (congenital emphysema) and CF.
AAT is not new as you no doubt know. Just delivering it in an aerosolized form is new (certainly easier than IV ).

 

[LisaV]

Thanks
This is really interesting to me as my late husband's family carries the genes for both alpha-one anti trypsin deficiency (congenital emphysema) and CF.
AAT is not new as you no doubt know. Just delivering it in an aerosolized form is new (certainly easier than IV ).

 

[LisaV]

Thanks
This is really interesting to me as my late husband's family carries the genes for both alpha-one anti trypsin deficiency (congenital emphysema) and CF.
AAT is not new as you no doubt know. Just delivering it in an aerosolized form is new (certainly easier than IV ).

 

[LisaV]

Thanks
This is really interesting to me as my late husband's family carries the genes for both alpha-one anti trypsin deficiency (congenital emphysema) and CF.
AAT is not new as you no doubt know. Just delivering it in an aerosolized form is new (certainly easier than IV ).

 

[LisaV]

Thanks
This is really interesting to me as my late husband's family carries the genes for both alpha-one anti trypsin deficiency (congenital emphysema) and CF.
AAT is not new as you no doubt know. Just delivering it in an aerosolized form is new (certainly easier than IV ).